Table 1 Patients’ and treatment characteristics
KG (n = 25) | IG (n = 25) | statistics | |
|---|---|---|---|
Indication | p = .62 1 | ||
primary RT | 6 (24%) | 6 (24%) | |
adjuvant RT | 10 (40%) | 7 (28%) | |
salvage RT | 9 (36%) | 12 (48%) | |
T-stage | p = 1.00 2 | ||
T2 | 12 (48%) | 11 (44%) | |
T2a | 4 (16%) | 1 (4%) | |
T2b | 1 (4%) | 0 | |
T2c | 6 (24%) | 10 (40%) | |
T2 (unspecified) | 1 (4%) | 0 | |
T3 | 13 (52%) | 13 (52%) | |
T3a | 12 (48%) | 10 (40%) | |
T3b | 1 (4%) | 2 (8%) | |
T3 (unspecified) | 0 | 1 (4%) | |
T4 | 0 | 1 (4%) | |
N-stage | p = 1.00 2 | ||
N0 | 22 (88%) | 23 (92%) | |
N1 | 3 (12%) | 2 (8%) | |
M-stage | p = 1.00 2 | ||
M0 | 24 (96%) | 24 (96%) | |
M1 | 1 (4%) | 1 (4%) | |
Gleason-Score | p = .22 2 | ||
6 | 2 (8%) | 1 (4%) | |
7a | 10 (40%) | 6 (24%) | |
7b | 6 (24%) | 14 (56%) | |
8 | 4 (16%) | 3 (12%) | |
9 | 3 (12%) | 1 (4%) | |
D’Amico risk | p = .50 2 | ||
low risk | 2 (8%) | 0 | |
intermediate risk | 4 (16%) | 6 (24%) | |
high risk | 19 (76%) | 19 (76%) | |
ADT | p = 1.00 2 | ||
yes | 4 (16%) | 3 (12%) | |
no | 21 (84%) | 22 (88%) | |
Age in years | p = .09 3 | ||
Mean (SD) | 69.3 (6,5) | 65.9 (7,2) | |
PSA in ng/ml | |||
primary RT: Mean (SD) | 16.3 (18.9) | 5.96 (5.9) | p = .39 4 |
adjuvant / Salvage RT: Mean (SD) | 0.3 (0.4) | 0.7 (1.2) | p = .31 4 |
Total Dose in Gy | |||
primary RT: Mean (SD) | 73.9 (2.6) | 76 (1.8) | p = .14 3 |
adjuvant / Salvage RT: Mean (SD) | 68.7 (2.2) | 69.1 (2.1) | p = .71 4 |
Usable CT scans | |||
Mean (SD) | 10.6 (2.0) | 11.2 (2.6) | p = .19 4 |